This site is intended for healthcare professionals
Drug news

CHMP recommends approval of Kadcyla for adjuvant treatment of HER2-positive early breast cancer.- Roche

Read time: 1 mins
Last updated:16th Nov 2019
Published:16th Nov 2019
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest